Joshua Bauml

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister et al. · Journal of Clinical Oncology · 2017 · 652 citations

Medicine, Oncology, Pharmacology +17

Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

Keunchil Park, Eric B. Haura, Natasha B. Leighl et al. · Journal of Clinical Oncology · 2021 · 632 citations · Full text

Medicine, Oncology, Pharmacology +17

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Stephen Bagley, Shawn Kothari, Charu Aggarwal et al. · Lung Cancer · 2017 · 529 citations

Medicine, Immunology, Oncology +16

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer

Charu Aggarwal, Jeffrey C. Thompson, Taylor A. Black et al. · JAMA Oncology · 2018 · 490 citations · Full text

Medicine, Genetics, Oncology +17

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Antonio Passaro, Jing Wang, Yan Wang et al. · Annals of Oncology · 2023 · 396 citations · Full text

Medicine, Oncology, Pharmacology +17